What the Tribunal Is

The Hepatitis C and HIV Compensation Tribunal is a statutory body that compensates people infected with Hepatitis C or HIV through contaminated blood products or transfusions within the State. It gives those affected, and in many cases their families, a route to a personal injury claim that does not depend on proving fault against any hospital, doctor, or State agency. It sits within the wider framework of personal injury law in Ireland, but it is a distinct statutory scheme rather than an ordinary court action.

The Tribunal was first established on 16 December 1995 on a non-statutory basis and began hearing claims in March 1996. It was placed on a statutory footing by the Hepatitis C Compensation Tribunal Act 1997, which commenced on 1 November 1997. Its remit was later widened to cover people infected with HIV, and the body is now known as the Hepatitis C and HIV Compensation Tribunal. The official Tribunal publishes its forms, guidance, and annual reports, and remains the authoritative source for anyone considering an application.

Why the Tribunal Was Established

The Tribunal grew out of one of the most serious public health failures in the history of the State. Large numbers of women were infected with Hepatitis C from contaminated Anti-D immunoglobulin distributed by the Blood Transfusion Service Board, and others were infected through blood transfusions and blood products. Some infected women unknowingly went on to donate blood before systematic screening was introduced in 1991, which widened the harm.

The High Court action taken by the late Brigid McCole, and the Quinlan case that followed, brought the scale of the failure into public view and led to a State apology. The Finlay Tribunal of Inquiry reported on the Anti-D contamination in 1997, and the later Lindsay Tribunal of Inquiry examined the infection of people with haemophilia through blood-clotting products. Faced with the prospect of forcing gravely ill people through adversarial litigation, the State created a permanent, non-adversarial scheme instead. People with haemophilia, who had earlier been dealt with under a separate settlement, were brought into the statutory scheme by the 2002 amendment.

Who Runs the Tribunal

The Tribunal is an independent statutory body whose members are appointed by the Minister for Health. It is led by a Chairperson and made up of ordinary members drawn from the ranks of practising senior counsel, junior counsel, and solicitors, several of whom specialise in medical negligence and personal injury work. Members are appointed for fixed terms and are reappointed from time to time, which is why the composition changes over the years while the Tribunal itself continues without interruption.

A claim is usually heard by three members sitting together, though the legislation allows a division of two members to hear an application. Hearings are recorded by stenographers, and each claimant receives a transcript of the proceedings through their solicitor. Because the members are legal practitioners rather than civil servants, the Tribunal operates with the independence of a judicial body while remaining a specialist scheme rather than a court.

Who Can Claim: The Ten Categories

The 1997 Act, as amended, sets out ten categories of person who may bring a claim. They cover the infected person, close family members who were themselves infected, carers who suffered financial loss, and dependants where the infection contributed to a death. The categories are lettered (a) to (j) in the legislation, and applications are made using one of three standard forms.

In practice, most primary infections are brought using a Form I application, dependency claims following a death use Form II, and claims for loss of consortium or for a carer's financial loss use Form III. The definition of a spouse was widened to include a cohabiting partner of at least three years, a change that applies from 6 July 2006. The official Tribunal notes that its category guidance is for information only and that applicants should take their own legal advice.

How the Tribunal Differs from a Court Claim

The defining feature of the Tribunal is that a claimant does not have to prove negligence. In an ordinary medical negligence action in the High Court, the injured person must establish fault by reference to the standard set in Dunne v National Maternity Hospital, usually with detailed expert evidence. Before the Tribunal, the claimant instead has to show, on the balance of probabilities, that the infection resulted from Anti-D, a transfusion, or a blood product received within the State. Section 4 of the 1997 Act provides that negligence need not be proved for an award of general and special damages, and the onus of proof on the claimant is set out in section 4(8) of the Act as amended.

That single difference changes the character of the whole process. Because there is no opposing party trying to defeat the claim on liability, the work is front-loaded into assembling documentary and medical evidence rather than contesting fault at a hearing. Hearings are held in private and usually conclude within a day, where a comparable court action could run for weeks. The Tribunal sits entirely outside the Injuries Resolution Board (IRB) process that applies to most personal injury claims, because it is a bespoke route to compensation for injury in Ireland with its own statutory rules.

What the Claimant Still Has to Prove

Removing the need to prove negligence does not remove the need to prove causation. The claimant must still establish, on the balance of probabilities, that the infection came from blood received within the State. In practice this means tracing the infection back through medical records, often to a specific blood unit number or to the batch number of a blood product. The products at the centre of these claims include anti-D immunoglobulin, whole blood transfusions, cryoprecipitate, factor concentrates, plasma, and red cell concentrates. Where a person received a large number of units of blood, that exposure may itself point to the likely source of infection. This tracing exercise, rather than any argument about fault, is where the real preparation of a Tribunal claim lies.

The Waiver: What You Give Up by Accepting

Accepting a Tribunal award is not cost-free in legal terms. On acceptance, the claimant signs a written waiver of any other right of action arising from the same infection and discontinues any related court proceedings. In effect, the Tribunal route and a court action are alternatives rather than steps in a sequence: taking an award closes off a separate claim over the same infection against the State or another party. That is why the choice between the two routes, and the timing of accepting an award, are decisions to take with legal advice rather than in isolation.

How a Claim to the Tribunal Works

A claim is built on documents first, and decided at a short private hearing. The claimant assembles medical records and evidence tracing the infection to blood received within the State, then lodges the application on the appropriate form. Because there is no opposing legal team seeking to dismantle the claim, the emphasis is on careful preparation rather than live contest. Hearings are held in camera, usually before three members of the Tribunal, at its offices at Bow Street in Dublin, and remote hearings have been available since October 2020 under a designation made by the Minister for Health during the pandemic (S.I. No. 428 of 2020).

The Tribunal currently offers a hearing date within one month of the required documents being lodged, and its public office is at 2nd Floor, 31-35 Bow Street, Dublin 7, D07 P8KD. Once the Tribunal makes an award, the claimant has one month from receiving notice of it to accept, reject, or appeal in writing under section 5(9)(a) of the 1997 Act, and a failure to respond within that period is treated as a rejection. If the award is accepted, payment is made within 28 days under section 5(12), and almost all applicants take a single lump sum, though the Tribunal may pay by instalments under section 5(11). The claimant then signs the waiver described above under section 5(10)(a). Where the successful claimant is a minor, acceptance of the award has to be approved by the High Court under section 5(13) to ensure it is in the child's interests, and the Tribunal awards the claimant's reasonable costs and expenses under section 5(5).

Settlement Without a Hearing

Not every claim requires an oral hearing. Under section 8 of the 1997 Act, an applicant may apply for a settlement without a hearing, in which the papers forming the basis of the claim are lodged and referred to a member of the Tribunal, who recommends whether an award should be made and, if so, how much. If that member is not satisfied that the applicant is entitled to an award, the claim is not dismissed. It is referred to a separate Division of the Tribunal for a decision on causation, and if that Division also decides against the applicant, the decision can be appealed to the High Court. This paper-based route can suit claimants who would find an oral hearing difficult, while preserving the same acceptance, payment, and appeal steps.

How Confidentiality Is Protected

Confidentiality is built into the scheme rather than left to discretion. Hearings are held in private, and the sensitive medical information in a claim is not made public. The 1997 Act also contains a specific safeguard for those who explore a settlement without a hearing: where a claimant applies for a settlement and does not accept it, the member who dealt with the settlement cannot sit on the division that later hears the claim, and the hearing division is not told that a settlement was ever applied for or rejected. This firewall, protected under section 8(2) of the Act, means a claimant can test a settlement without prejudicing a later hearing.

Awards, the Reparation Fund and Provisional Awards

Awards are calculated on the same basis as damages in a High Court personal injury action, with two features unique to this scheme. The Tribunal assesses general damages for pain and suffering and special damages for financial losses such as care, equipment, and lost earnings. The two distinctive features are the Reparation Fund and the provisional award, both of which reflect the specific history of the blood scandal.

The Reparation Fund, established under the 1997 Act, allows a claimant who accepts an award or settlement to receive an additional amount fixed at 20 per cent of the total, paid in lieu of the Tribunal assessing aggravated or exemplary damages. This recognises the State's systemic failure without requiring every claimant to argue the point individually. A claimant who instead seeks and obtains a specific award of aggravated or exemplary damages from the Tribunal does not also draw the 20 per cent uplift. The Fund is financed through the Oireachtas and audited by the Comptroller and Auditor General.

The provisional award is a significant departure from the ordinary rule that a personal injury settlement is final and cannot be revisited. Recognising the unpredictable, degenerative nature of these infections, the 1997 Act gives a claimant the right to a provisional award where there is a possibility, but not a probability, of a serious future consequence. The initial award is assessed on the basis that the consequence will not happen. If it later does, the claimant may return to the Tribunal for further compensation. This matters increasingly as the original cohort ages and some claimants who received provisional awards years ago now experience the very deterioration those awards anticipated.

Interim Awards and Provisional Awards Are Not the Same

These two mechanisms are easily confused but do different jobs. An interim award is used where a claimant is not yet in a position to present the claim in full, for example while still undergoing treatment and without a settled prognosis. It provides compensation in the meantime, in exceptional circumstances, with the balance assessed later. A provisional award, by contrast, is a final assessment made on the basis that a possible serious future consequence will not occur, coupled with the right to return if it does. In short, an interim award addresses a claim that is not yet ready to value, while a provisional award addresses a future medical risk that cannot yet be valued.

The Three Acts: How the Scheme Was Built

The scheme rests on a principal Act of 1997 and two later amendments, each of which widened it. Reading the three together shows how the State's response expanded from the original Anti-D cohort to a broader group of infected people and their families. The table below sets out the sequence in chronological order.

The 2002 change to fatal claims is notable in its own right. In an ordinary fatal case, the dependants of a deceased person cannot recover general damages for the pain and suffering the deceased endured before death. The 2002 Act created an exception to that long-standing rule for this scheme, allowing dependants to claim for that suffering. This is one of several ways in which the Tribunal departs from the ordinary position under the Civil Liability Act 1961.

Appealing a Tribunal Decision to the High Court

A claimant who is dissatisfied with a decision or an award can appeal to the High Court. The appeal is brought by originating notice of motion, which must generally issue within one month of the claimant receiving notice of the award. As with the Tribunal itself, these appeals are heard in private to protect the claimant's confidentiality. The procedure is governed by Order 105A of the Rules of the Superior Courts, inserted in 1998 specifically to deal with these appeals.

The Minister for Health holds a corresponding right to cross-appeal, most often where the Minister wishes to challenge an award of aggravated or exemplary damages. A decision of the High Court on such an appeal is generally final. The one exception is that, by leave of the High Court, a further appeal may lie to the Supreme Court, but only on a specified point of law and not on a dispute about the facts or the amount of an award.

Related Supports: Tax Treatment and the HAA Card

Compensation from the Tribunal carries favourable tax treatment and opens the door to further health supports. Payments made by the Tribunal, including the Reparation Fund uplift, are exempt from income tax and capital gains tax under section 191 of the Taxes Consolidation Act 1997. Income and gains from investing that compensation can also be exempt under section 189, and Revenue accepts by published concession that infected claimants meet the incapacity condition without a separate adversarial assessment. Anyone in this position should still take specialist tax advice on their own circumstances.

Separately, people infected through contaminated blood can access a Health (Amendment) Act Card, which provides a range of health services without charge, and the insurance scheme underpinned by the 2006 Act. These supports sit alongside compensation rather than forming part of it. General guidance on the health card is available from Citizens Information.

Key Terms Explained

A few technical terms recur throughout the Tribunal scheme, and understanding them makes the rest of the process clearer. The definitions below explain how each term is used in this specific context.

Provisional award

A final award assessed on the basis that a possible serious future consequence will not occur, with a right to return to the Tribunal if it does.

Interim award

Compensation made in exceptional circumstances while a claim cannot yet be presented in full, for example during ongoing treatment, with the balance assessed later.

Reparation fund

A fund from which a claimant may receive an extra amount fixed at 20 per cent of the award, in lieu of the Tribunal assessing aggravated or exemplary damages.

Loss of consortium

The loss of the companionship and relationship of an infected spouse or long-term partner, including the impairment of the couple's relationship arising from the risk of transmission.

In camera

A hearing held in private, closed to the public and press, attended only by the Tribunal, the claimant, and their legal and medical representatives.

Waiver

The written agreement a claimant signs on accepting an award, giving up any other right of action arising from the same infection.

Relevant product

The blood product through which HIV infection occurred, as defined for the purposes of the HIV categories added by the 2002 Act.

How to Bring a Claim to the Tribunal

Bringing a claim follows a defined sequence of steps, from identifying the right category to accepting or appealing the award. The outline below shows how a claim moves through the scheme. It is a general guide to the process rather than legal advice, and most claimants are legally represented at each stage.

1. Identify the correct category. Work out which of the ten statutory categories applies, because that determines both the application form and the time limit.
2. Choose the application form. Use Form I for a primary infection, Form II for a dependency claim after a death, or Form III for loss of consortium or a carer's financial loss.
3. Gather the evidence and trace the source. Assemble medical records and trace the infection to blood received within the State, often to a specific unit or batch number.
4. Lodge the application. Submit the completed form and supporting documents to the Tribunal.
5. Choose a hearing or a settlement without a hearing. The claim proceeds either to a private oral hearing or, under section 8, to a paper-based settlement decided by a member.
6. Receive the award. The Tribunal assesses general and special damages, and the claimant may apply for the 20 per cent reparation fund payment.
7. Accept, reject, or appeal. Within one month, accept the award and sign the waiver, or appeal to the High Court.

Frequently Asked Questions